No significant HTLV seroprevalence in German people who inject drugs.

about

No significant HTLV seroprevalence in German people who inject drugs.

Item

http://www.wikidata.org/entity/Q40075316

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

No significant HTLV seroprevalence in German people who inject drugs.

@en

type

Item

label

No significant HTLV seroprevalence in German people who inject drugs.

@en

prefLabel

No significant HTLV seroprevalence in German people who inject drugs.

@en

P1476

No significant HTLV seroprevalence in German people who inject drugs.

@en

P2093

Claudia Kücherer

http://www.w3.org/2001/XMLSchema#string

Hiba El Hajj

http://www.w3.org/2001/XMLSchema#string

Norbert Bannert

http://www.w3.org/2001/XMLSchema#string

Ruth Zimmermann

http://www.w3.org/2001/XMLSchema#string

Stephen Norley

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters.

Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa

HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology.

The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy.

Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses.

Increased all-cause and cancer mortality in HTLV-II infection.

A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.

The epidemiology and disease outcomes of human T-lymphotropic virus type II.

P304

e0183496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0183496

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28829831

http://www.w3.org/2001/XMLSchema#string

P921

Seroprevalence

P932

5567501

http://www.w3.org/2001/XMLSchema#string